Holland
EDWARDSVILLE The parents of a boy born prematurely are suing Mead Johnson and Abbott for allegedly failing to warn that their infant formula products could cause a serious gastrointestinal disorder and other health issues in premature infants.
Destin Jupiter and Dana Jupiter filed a complaint May 7 in the Madison County Circuit Court against Mead Johnson & Company LLC, Mead Johnson Nutrition Company and Abbott Laboratories, alleging strict liability for design defect and for failure to warn, negligence and intentional and negligent misrepresentation.
The Jupiters allege in their complaint that their son was born prematurely on May 9, 2002, at Woman s Hospital in Baton Rouge, La. They claim he has developed necrotizing enterocolitis (NEC) and other long-term health effects because he was given Simlac and/or Enfamil cow s milk-based products after birth and during his hospital stay.
Callis
EDWARDSVILLE A mother claims her premature infant son developed a serious condition requiring part of his intestines to be removed after he was given Similac and Enfamil cow s milk-based formula.
Takia Smith, on her own behalf and on the behalf of her minor child Amir Lattimore, filed a complaint May 10 in the Madison County Circuit Court against Mead Johnson & Company LLC, Mead Johnson Nutrition Company and Abbott Laboratories alleging strict liability for design defect, failure to warn, negligence and negligent misrepresentation.
According to Smith s complaint, her son Amir was born prematurely at St. Mary s Medical Center in West Palm Beach, Fla., on May 13, 2017, and was fed Similac and/or Enfamil cow s milk-based products during his hospital stay. Smith alleges that her son developed necrotizing enterocolitis (NEC) a potentially deadly life-altertng disease, after first ingesting the defendant s cow s milk-based products. She claims he
Share:
Portland, OR, May 13, 2021 (GLOBE NEWSWIRE) According to the report published by Allied Market Research, the global
protein ingredients market generated $53.78 billion in 2019, and is expected to reach $91.89 billion by 2027, witnessing a CAGR of 6.4% from 2021 to 2027. The report offers an extensive analysis of changing market trends, key segments, top investment pockets, value chain, competitive landscape, and regional scenario.
Increase in per capita income, consumer awareness about healthy diet, demand for proteins as nutritional and functional ingredients, and surge in consumption through natural sports drinks drive the growth of the global protein ingredients market. However, undefined regulatory guidelines and high cost of clean label protein ingredient products hinder the market growth. On the other hand, introduction of protein supplements in untapped markets and product innovations create new opportunities in the coming years.